Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous malignancy marked by a differentiation block in myeloid progenitors. Despite advances in molecular-targeted therapies, long-term outcomes remain poor, underscoring the need for novel tr... ...

请注册登录后继续浏览